Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Poor Response to Neoadjuvant Chemotherapy Correlates with Mast Cell Infiltration in Inflammatory Breast Cancer
Sangeetha M. Reddy, Alexandre Reuben, Souptik Barua, et al.
Cancer Immunology Research (2019) Vol. 7, Iss. 6, pp. 1025-1035
Open Access | Times Cited: 85

Showing 1-25 of 85 citing articles:

B cells and tertiary lymphoid structures promote immunotherapy response
Beth A. Helmink, Sangeetha M. Reddy, Jianjun Gao, et al.
Nature (2020) Vol. 577, Iss. 7791, pp. 549-555
Open Access | Times Cited: 1990
Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy
Rajasekharan Somasundaram, Thomas Connelly, Robin Choi, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 149
Mast Cells: A New Frontier for Cancer Immunotherapy
Jake Lichterman, Sangeetha M. Reddy
Cells (2021) Vol. 10, Iss. 6, pp. 1270-1270
Open Access | Times Cited: 104
Towards targeting the breast cancer immune microenvironment
Michael A. Harris, Peter Savas, Balaji Virassamy, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 8, pp. 554-577
Closed Access | Times Cited: 53
Mast Cells in the Tumor Microenvironment
Angélica Aponte-López, Samira Muñoz-Cruz
Advances in experimental medicine and biology (2020), pp. 159-173
Closed Access | Times Cited: 127
T follicular helper and B cell crosstalk in tertiary lymphoid structures and cancer immunotherapy
Soizic Garaud, Marie‐Caroline Dieu‐Nosjean, Karen Willard‐Gallo
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 52
Few, but Efficient: The Role of Mast Cells in Breast Cancer and Other Solid Tumors
Maria Teresa Majorini, Mario P. Colombo, Daniele Lecis
Cancer Research (2022) Vol. 82, Iss. 8, pp. 1439-1447
Open Access | Times Cited: 41
Mast cells in colorectal cancer tumour progression, angiogenesis, and lymphangiogenesis
Xiaoxin Liu, Xinyu Li, Haotian Wei, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 31
Mast Cells as a Target—A Comprehensive Review of Recent Therapeutic Approaches
Joanna Baran, Anna Sobiepanek, Anna Mazurkiewicz-Pisarek, et al.
Cells (2023) Vol. 12, Iss. 8, pp. 1187-1187
Open Access | Times Cited: 30
Clinical and biomarker analyses of sintilimab plus gemcitabine and cisplatin as first-line treatment for patients with advanced biliary tract cancer
Tianmei Zeng, Guang Yang, Cheng Lou, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Prognostic value of CD163+ macrophages in solid tumor malignancies: A scoping review
Henriette Mathiesen, Kristian Juul‐Madsen, Trine Tramm, et al.
Immunology Letters (2025), pp. 106970-106970
Open Access | Times Cited: 1
Comprehensive Analysis of Pyroptosis-Related Genes and Tumor Microenvironment Infiltration Characterization in Breast Cancer
Jianbin Wu, Yuanyuan Zhu, Mingmin Luo, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 54
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer
Xiaoping Wang, Takashi Semba, Ganiraju C. Manyam, et al.
Science Advances (2022) Vol. 8, Iss. 50
Open Access | Times Cited: 37
T-Cell Receptor Repertoire Sequencing in the Era of Cancer Immunotherapy
Meredith Frank, Kaylene Lu, Can Erdogan, et al.
Clinical Cancer Research (2022) Vol. 29, Iss. 6, pp. 994-1008
Open Access | Times Cited: 28
Infiltrating Mast Cell–Mediated Stimulation of Estrogen Receptor Activity in Breast Cancer Cells Promotes the Luminal Phenotype
Maria Teresa Majorini, Valeria Cancila, Alice Rigoni, et al.
Cancer Research (2020) Vol. 80, Iss. 11, pp. 2311-2324
Open Access | Times Cited: 48
Development and validation of a stromal immune phenotype classifier for predicting immune activity and prognosis in triple‐negative breast cancer
Shaoquan Zheng, Yutian Zou, Xinhua Xie, et al.
International Journal of Cancer (2020) Vol. 147, Iss. 2, pp. 542-553
Open Access | Times Cited: 48
Prognostic significance of spatial immune profiles in human solid cancers
Takahiro Tsujikawa, Junichi Mitsuda, Hiroshi Ogi, et al.
Cancer Science (2020) Vol. 111, Iss. 10, pp. 3426-3434
Open Access | Times Cited: 48
Identification and validation of an immune cell infiltrating score predicting survival in patients with lung adenocarcinoma
Xiaodong Yang, Yu Shi, Ming Li, et al.
Journal of Translational Medicine (2019) Vol. 17, Iss. 1
Open Access | Times Cited: 43
Emerging Roles of Mast Cells in the Regulation of Lymphatic Immuno-Physiology
Sarit Pal, Shubhankar Nath, Cynthia J. Meininger, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 40
Immune landscape of inflammatory breast cancer suggests vulnerability to immune checkpoint inhibitors
François Bertucci, Laurys Boudin, Pascal Finetti, et al.
OncoImmunology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 36
Controversial role of mast cells in breast cancer tumor progression and angiogenesis
Doménico Ribatti, Tiziana Annese, Roberto Tamma
Clinical Breast Cancer (2021) Vol. 21, Iss. 6, pp. 486-491
Closed Access | Times Cited: 34
Focus on mast cells in the tumor microenvironment: Current knowledge and future directions
Saimeng Shi, Long‐Yun Ye, Xianjun Yu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1878, Iss. 1, pp. 188845-188845
Closed Access | Times Cited: 25
Depression in breast cancer patients: Immunopathogenesis and immunotherapy
Sheng Yu, Wen Li, Lingxue Tang, et al.
Cancer Letters (2022) Vol. 536, pp. 215648-215648
Closed Access | Times Cited: 23
Neoadjuvant chemotherapy-induced remodeling of human hormonal receptor-positive breast cancer revealed by single-cell RNA sequencing
Fang Jia, Shanshan Sun, Jiaxin Li, et al.
Cancer Letters (2024) Vol. 585, pp. 216656-216656
Open Access | Times Cited: 5
Stromal infiltrating mast cells identify immunoevasive subtype high-grade serous ovarian cancer with poor prognosis and inferior immunotherapeutic response
Kankan Cao, Guodong Zhang, Xiangyun Zhang, et al.
OncoImmunology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top